Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus

Title:Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus

Volume: 14 Issue: 7

Author(s): Jenniffer Cruz, Paola Rondon-Villarreal, Rodrigo G. Torres, Mauricio Urquiza, Fanny Guzman, Claudio Alvarez, Maria A. Abengozar, Daniel A. Sierra, Luis Rivas, Roberto Fernandez-Lafuente and Claudia C. Ortiz*

Affiliation:

• Grupo de Investigacion en Bioquimica y Microbiologia (GIBIM), Escuela de Microbiologia y Bioanalisis, Universidad Industrial de Santander, Edificio Camilo Torres 202, Bucaramanga,Colombia

Keywords: Genetic algorithm, peptide design, antimicrobial peptides, pathogen bacterial, peptide synthesis, fluorescence microscopy.

Abstract: Background: Antimicrobial peptides are on the first line of defense against pathogenic microorganisms of many living beings. These compounds are considered natural antibiotics that can overcome bacterial resistance to conventional antibiotics. Due to this characteristic, new peptides with improved properties are quite appealing for designing new strategies for fighting pathogenic bacteria.

Methods: Sixteen designed peptides were synthesized using Fmoc chemistry; five of them are new cationic antimicrobial peptides (CAMPs) designed using a genetic algorithm that optimizes the antibacterial activity based on selected physicochemical descriptors and 11 analog peptides derived from these five peptides were designed and constructed by single amino acid substitutions. These 16 peptides were structurally characterized and their biological activity was determined against Escherichia coli O157:H7 (E. coli O157:H7), and methicillin-resistant strains of Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (P. aeruginosa) were determined.

Results: These 16 peptides were folded into an α-helix structure in membrane-mimicking environment. Among these 16 peptides, GIBIM-P5S9K (ATKKCGLFKILKGVGKI) showed the highest antimicrobial activity against E. coli O157:H7 (MIC=10µM), methicillin-resistant Staphylococcus aureus (MRSA) (MIC=25µM) and Pseudomonas aeruginosa (MIC=10 µM). Peptide GIBIM-P5S9K caused permeabilization of the bacterial membrane at 25 µM as determined by the Sytox Green uptake assay and the labelling of these bacteria by using the fluoresceinated peptide. GIBIM-P5S9K seems to be specific for these bacteria because at 50 µM, it provoked lower than 40% of erythrocyte hemolysis.

Conclusion: New CAMPs have been designed using a genetic algorithm based on selected physicochemical descriptors and single amino acid substitution. These CAMPs interacted quite specifically with the bacterial cell membrane, GIBIM-P5S9K exhibiting high antibacterial activity on Escherichia coli O157:H7, methicillin-resistant strains of Staphylococcus aureus and P. aeruginosa.

Cite this article as:

Cruz Jenniffer, Rondon-Villarreal Paola, Torres G. Rodrigo, Urquiza Mauricio, Guzman Fanny, Alvarez Claudio, Abengozar A. Maria , Sierra A. Daniel , Rivas Luis, Fernandez-Lafuente Roberto and Ortiz C. Claudia*, Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus, Medicinal Chemistry 2018; 14 (7) . https://dx.doi.org/10.2174/1573406414666180508120024